| Share-based compensation |
Note 12 — Share-based compensation
The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
|
|
September 30, |
|
September 30, |
|
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
Research and development |
|
$ |
2,177 |
|
$ |
1,219 |
|
$ |
7,064 |
|
$ |
3,126 |
|
|
General and administrative |
|
|
2,842 |
|
|
2,061 |
|
|
8,738 |
|
|
4,226 |
|
|
|
|
$ |
5,019 |
|
$ |
3,280 |
|
$ |
15,802 |
|
$ |
7,352 |
|
|
The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
|
September 30, |
|
September 30, |
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
Number of options over ordinary shares granted |
|
|
4,170,230 |
|
|
1,882,966 |
|
|
19,891,334 |
|
|
14,851,182 |
|
Weighted average fair value of ordinary shares options |
|
$ |
0.51 |
|
$ |
1.25 |
|
$ |
0.70 |
|
$ |
0.57 |
|
Number of additional options with a nominal exercise price granted |
|
|
1,348,920 |
|
|
571,320 |
|
|
16,008,168 |
|
|
7,410,136 |
|
Weighted average fair value of options with a nominal exercise price |
|
$ |
0.70 |
|
$ |
1.70 |
|
$ |
0.98 |
|
$ |
0.78 |
|
|